On October 25th, Christian Bachofen, the founder and chief designer of CB Consultancy AG (hereinafter referred to as CBC) and the chief technology officer of Biomedicine of TIANS Group, came to TIANS Group and held a strategic cooperation forum with the main leaders of TIANS Group At the meeting, the two parties had in-depth exchanges on further deepening strategic cooperation, promoting the development of biomedicine, the development of environmental protection industry, and the future development strategy of the group.

TIANS Group Vice Chairman Liu Song and Liu Jintao, Director, President and Chief Technology Officer Wu Yafeng, Director and Vice President Zhang Xinqiao, Vice President and Chairman of the Biomedicine Division Song Xiaohui, Vice President and General Manager of the Chemical Medicine Division Peng Ting, Zhou Lanxia, General Manager of Biomedical Design Company, and Mr. Christian attended the meeting.

Mr. Christian Bachofen had a discussion meeting with the leaders of TIANS Group

Liu Song, vice chairman of TIANS Group, first expressed his welcome and gratitude to Mr. Christian for coming. He said that TIANS Group, as a well-known large-scale pharmaceutical and environmental protection project construction general contracting service provider in China, has focused on EPC since 2011. In the development process of more than ten years, the current business scope covers ten major sectors including engineering consulting and design, general contracting of biomedical engineering, general contracting of chemical and pharmaceutical engineering, environmental protection technology and general contracting of engineering. Many biopharmaceutical companies such as Jeshenju, Junshi Bio, Shanghai Pharmaceutical Kangsino, and Si Microbiology have built many high-quality projects. The cooperation with CBC will further strengthen the group's industry depth and business breadth in the biomedical sector, and create the group's biomedical industry. New situation in medicine. At the same time, he also said that the past ten years have been the stage of rapid development of China's construction industry and pharmaceutical industry, and hope to make its own contribution to the development of China's pharmaceutical industry with CBC.

Mr. Christian made a systematic introduction from CBC's company structure, business capabilities and project cases. Mr. Christian said that CBC is a leading consulting, planning and engineering service provider, providing consulting services during the construction phase and the entire life cycle for industrial plants in the pharmaceutical and biotechnology industries. Since its establishment in 2012, it has an excellent track record and a deep understanding of the needs of customers in Switzerland and Asia. Has designed the Johnson & Johnson Pharmaceutical freeze-dried antibody production plant and the monoclonal antibody-xilin bottle packaging line design project, the Novartis Pharmaceutical R&D Park office building and the laboratory design project for R&D, the BeiGene Suzhou pilot production workshop and the commercialization in Guangzhou The design project of the production workshop and many projects such as the new crown vaccine production workshop of Zhongsheng Group.

Afterwards, the participants conducted in-depth discussions on the main directions, principles and development goals of the cooperation between the two parties. Work together and go hand in hand. In the future, under the joint efforts of TIANS Group and CBC led by Mr. Christian, it will create more possibilities for the future development of China's biomedicine and build benchmark projects one after another.